Cargando…

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma

BACKGROUND: External beam radiotherapy (EBRT) is the treatment of choice for irresectable meningioma. Due to the strong expression of somatostatin receptors, peptide receptor radionuclide therapy (PRRT) has been used in advanced cases. We assessed the feasibility and tolerability of a combination of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kreissl, Michael C, Hänscheid, Heribert, Löhr, Mario, Verburg, Frederik A, Schiller, Markus, Lassmann, Michael, Reiners, Christoph, Samnick, Samuel S, Buck, Andreas K, Flentje, Michael, Sweeney, Reinhart A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439242/ https://www.ncbi.nlm.nih.gov/pubmed/22720902 http://dx.doi.org/10.1186/1748-717X-7-99

Ejemplares similares

Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
por: Hartrampf, Philipp E., et al.
Publicado: (2020)

Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients
por: Lapa, Constantin, et al.
Publicado: (2018)

Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
por: Guckenberger, Matthias, et al.
Publicado: (2012)

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
por: Lapa, Constantin, et al.
Publicado: (2016)

Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
por: Fodi, Christina-Katharina, et al.
Publicado: (2022)

DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy
por: Eberlein, Uta, et al.
Publicado: (2015)

(68)Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with(18)F-FDG, calcium burden and risk factors
por: Li, Xiang, et al.
Publicado: (2012)

Is the Image Quality of I-124-PET Impaired by an Automatic Correction of Prompt Gammas?
por: Preylowski, Veronika, et al.
Publicado: (2013)

The impact of (177)Lu-octreotide therapy on (99m)Tc-MAG3 clearance is not predictive for late nephropathy
por: Werner, Rudolf A., et al.
Publicado: (2016)

GATE/Geant4-based dosimetry for ex vivo in solution irradiation of blood with radionuclides
por: Salas-Ramirez, Maikol, et al.
Publicado: (2022)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2012)

[(177)Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent
por: Schottelius, Margret, et al.
Publicado: (2017)

Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results
por: Wilbert, Jürgen, et al.
Publicado: (2010)

Intraindividual comparison of [(177)Lu]Lu-DOTA-EB-TATE and [(177)Lu]Lu-DOTA-TOC
por: Hänscheid, Heribert, et al.
Publicado: (2021)

Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors
por: Sweeney, Reinhart A, et al.
Publicado: (2012)

EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
por: Konijnenberg, Mark, et al.
Publicado: (2020)

Radionuclide Imaging in Cancer Management
por: Maisey, Michael
Publicado: (1998)

Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
por: Lapa, Constantin, et al.
Publicado: (2014)

Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population
por: Eilsberger, Friederike, et al.
Publicado: (2023)

CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
por: Lapa, Constantin, et al.
Publicado: (2017)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2018)

Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma
por: Lisowski, Dominik, et al.
Publicado: (2022)

Distribution of uranium and thorium chains radionuclides in different fractions of phosphogypsum grains
por: Szajerski, Piotr
Publicado: (2020)

Modelling PET Radionuclides Production in Tissue and External Targets Using Geant4
por: Amin, Tanjil, et al.
Publicado: (2017)

Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
por: Zandee, Wouter T, et al.
Publicado: (2021)

Radionuclide and metal sorption on cement and concrete
por: Ochs, Michael, et al.
Publicado: (2016)

The management of symptomatic hyperostotic bilateral spheno-orbital meningiomas: patient series
por: Harris, Lauren, et al.
Publicado: (2023)

Meningioma in the elderly
por: Amoo, Michael, et al.
Publicado: (2023)

Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
por: Werner, R. A., et al.
Publicado: (2016)

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment
por: Werner, R.A., et al.
Publicado: (2015)

Role of Radionuclide Therapy as Adjuvant to Palliative External Beam Radiotherapy for Painful Multiple Skeletal Metastasis
por: Hicsonmez, Ayse, et al.
Publicado: (2010)

Radionuclide Imaging of Neurohormonal System of the Heart
por: Chen, Xinyu, et al.
Publicado: (2015)

Radiopharmaceuticals and other compounds labelled with short-lived radionuclides
por: Welch, Michael J
Publicado: (2013)

Clear-cell meningioma presenting as an infiltrative external auditory canal mass
por: Foster, Sarah, et al.
Publicado: (2015)

Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas
por: Oermann, Eric Karl, et al.
Publicado: (2013)

From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
por: Flux, G. D., et al.
Publicado: (2017)

Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
por: Ljungberg, Michael, et al.
Publicado: (2015)

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives
por: Verburg, Frederik A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p9u8dh9iia0q527kffip3ke7g9